Apollo Hospitals Enterprise Ltd

Q4 FY26Healthcare Services

Apollo Hospitals Enterprise Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹8,878

Market cap₹1.2L Cr

P/E59.4

Updated25 Aug 2026

Read4 min read

What the Q4 FY26 call signalled

3 of 3 strong

RevenueGood growth

MarginMargins slightly up

CapexCapex planned

The short version

Apollo HealthCo aims for INR 25,000 crore revenue run rate by Q4 FY27, growing from INR 19,000 crore pro forma basis in FY26, targeting 21% growth. Company expects overall Healthcare Services to deliver mid-teen revenue growth in FY27 with improved margins by at least 100 bps in established units.

From Apollo Hospitals Enterprise Ltd's Q4 FY26 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Good growth

Apollo HealthCo aims for INR 25,000 crore revenue run rate by Q4 FY27, growing from INR 19,000 crore pro forma basis in FY26, targeting 21% growth.
30% growth currently driven by top 5 markets; expansion planned into new markets.
Pharmacy business acquiring 200,000-220,000 new customers monthly, expected to increase with 7,500 outlets synergy.
Diagnostics business growing 25%-30%, with plans to further grow and strengthen through integration.
Hospital services targeting mid-teen revenue growth in FY27; expecting gradual revenue acceleration and better asset utilization.
New hospitals adding about 1,400 beds, with phased commissioning; 500-600 beds expected operational by mid-FY27.

2 more points management made on revenue & sales performance

Profitability & Margins

Company expects overall Healthcare Services to deliver mid-teen revenue growth in FY27 with improved margins by at least 100 bps in established units.
Hospitals business EBITDA loss anticipated around INR 150 crore for FY27, with peak losses in Q4 due to new hospital ramps.
Apollo HealthCo (AHLL) aims for INR 25,000 crore run-rate revenue by Q4 FY27, growing at about 21% annually with EBITDA margin guidance of 6.5% to 7%.
Digital business projected to break even including ESOP costs by Q3 FY27, contributing positively to EBITDA.
Established hospitals expected to continue margin expansion beyond current ~25.5% through asset utilization and cost optimization.

2 more points management made on profitability & margins

See what Apollo Hospitals Enterprise Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned

Growth capex for hospitals is expected to continue at around INR 550 crore annually, considered fully redeployable for expansion.
INR 1,980 crore capex is planned for FY27 to commission 1,000 new beds.
Four new hospitals operationalized in FY26 with 855 beds capacity; 185 beds operationalized, remaining 670 beds to be commissioned over next 12 months.
Two more hospitals (Sarjapur and Gurugram) expected to be commissioned in the next two quarters, adding up to approximately 1,400 beds in metro markets by FY28.
Investments ongoing in clinical leadership (oncology, robotics, advanced care), technology, and digital health to improve consumer engagement and operational integration.

2 more points management made on capital expenditure plans

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Health X Platform₹919 Cr

Rev 1Mar 1

2Chandan Healthca₹590 Cr

Rev 1Mar 3

3₹66.2K Cr

Rev 2Mar 1

4₹1.8K Cr

Rev 2Mar 2

5₹649 Cr

Rev 2Mar 2

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

No explicit mention of any new fundraising through debt or equity during the call.
The company paid off INR 1,250 crore to buy out IFC this quarter from the Healthcare Services balance sheet.
Capex for growth continues with INR 1,550 crore re-deployable for growth capex, expected to continue similarly in the coming year.
The company plans to sustain growth capex without significantly increasing this number next year.

2 more points management made on fundraising & capital structure

See what Apollo Hospitals Enterprise Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly provide information about current or expected orderbook or pending orders for Apollo Hospitals Limited or its subsidiaries. The discussion primarily focuses on business performance, expansion plans, hospital bed additions, digital platforms, and legal matters related to Indraprastha Medical. No specific mention of orderbook or pending orders was made in the provided pages.

Apollo Hospitals Enterprise Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹6.6K Cr, net profit ₹551 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Apollo Hospitals Enterprise Ltd's management said in earlier quarters

Others in Healthcare Services this season

KMC Speciality Hospitals (India) Ltd (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
Star Imaging (Q4 FY26)
Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…
Gaudium IVF (Q4 FY26)
Revenue growth seen in FY26: INR 104.35 crore, a 47.56% increase from FY25. Key concall takeaways from Gaudium IVF's Q4 FY26 earnings call — and how it ranks…
Health X Platform Ltd (Q4 FY26)
Northeast operations growing 50%+ year-on-year and Northern India 25–30%, with plans for 5–7% market share in 2-3 years (Page 10). Key concall takeaways from…

Compare:vs Max Healthcare vs Manipal Health vs Aster DM Quality

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Apollo Hospitals Enterprise Ltd Q4 FY26 results?

What is Apollo Hospitals Enterprise Ltd share price analysis?

Apollo Hospitals Enterprise Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 59.4 with a market cap of ₹124,992 Cr. Investors should review the full earnings analysis for detailed insights.

Is Apollo Hospitals Enterprise Ltd planning capital expenditure?

Growth capex for hospitals is expected to continue at around INR 550 crore annually, considered fully redeployable for expansion.

Keep Apollo Hospitals Enterprise Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.